Made available in DSpace on 2014-06-11T19:33:28Z (GMT). No. of bitstreams: 0 Previous issue date: 2004-08-31Bitstream added on 2014-06-13T19:44:16Z : No. of bitstreams: 1 marcaccini_am_dr_arafo.pdf: 3610599 bytes, checksum: 65fbbd0cb1b0657f1b361bf4e461a54e (MD5) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Os objetivos deste estudo foram avaliar o efeito de biomateriais associados ao PRP na formação óssea em defeitos padronizados de rádio e avaliar o efeito de PRP+RTG+enxerto ósseo autógeno para tratamento de lesões de furca grau II em cães. Para tal, em um primeiro estudo, foram confeccionados 5 defeitos de 5mm em cada rádio (direito e esquerdo) em 05 cães, constituindo assim espaços para preenchimento com os enxertos ou substitutos ósseos avaliados, totalizando 50 cavidades. Os materiais testados foram DFDBA, vidro bioativo, osso autógeno e osso mineral bovino, associados ou não ao PRP. Estes grupos foram avaliados e comparados com os grupos representados por coágulo sangüíneo e PRP. Ao final de 60 dias, foi realizada biópsia e preparo laboratorial para avaliação histológica e histomorfométrica. Os grupos que apresentaram melhores resultados foram coágulo, PRP e osso autógeno associado ou não a PRP; e a utilização do PRP não promoveu maior formação óssea em relação aos demais grupos, com exceção do vidro bioativo+PRP que apresentou os melhores resultados. No segundo estudo, foram criados cirurgicamente defeitos periodontais de furca nos quartos pré-molares mandibulares, bilateralmente em 5 cães, cronificados por um período de três meses e tratados por PRP/RTG/enxerto ósseo autógeno (grupo experimental) ou RTG/enxerto ósseo autógeno (grupo controle). Quatro meses após o tratamento, os cães foram sacrificados. Na área de furca, houve maior preenchimento ósseo e extensão linear de novo cemento, nova adaptação conjuntiva e regeneração periodontal no grupo experimental (p<0.005) e maior extensão linear de epitélio no grupo controle (p<0.005). A associação do PRP a RTG e enxerto ósseo autógeno proporcionou maior regeneração dos tecidos periodontais. Portanto, o PRP promoveu melhores resultados na formação óssea somente... . / The aims of this study were to evaluate the effect of biomaterials in association to PRP on bone formation, in padronized defects of radius, and evaluate the effect of PRP/GTR/autogenous bone graft in the treatment of Class II furcation lesions in dogs. For that, in a first study, five defects of 5mm each were produced in each radius (left and right) in 5 dogs, so creating spaces to be filled with grafts or the bone substitutes under study, totalling 50 cavities. The biomaterials tested were DFDBA, bioglass, autogenous bone and bovine mineral bone grafts, associated, or not, with PRP. These biomaterials were compared with coagulum and PRP. At the end of 60 days biopsy was done and histological laminas were prepared. Under the experimental condictions, coagulum, PRP and autogenous bone associated or not to PRP presented the best results, with more new bone formation; and no difference was observed between the groups with biomaterials, associated or not with PRP, excepting bioactive glass/PRP which showded the best results. In the second study, periodontal furcation defects were surgically produced bilaterally in the fourth mandibular premolars in 5 dogs, cronified for 3 months and treated with PRP/GTR/autogenous bone graft (experimental group) or GTR/autogenous bone graft (control group). Four months after the treatment, the dogs were sacrified. In the furcation area, more bone filling and linear extension of new cement, new conjunctive adaptation and periodontal regeneration were observed to occur in the experimental group (p<0.005) and more linear extension of epitelium in the control group (p<0.005). The association PRP/GTR/autogenous bone graft was observed to produce more regeneration of periodontal tissues. Therefore, the PRP association showed the best results in bone formation only at bioactive glass group; and... (Complete abstract, click electronic address below).

Orientador: Elcio Marcantonio Junior / Banca: Joni Augusto Cirelli / Banca: Enilson Antonio Sallum / Banca: Luis Carlos Spolidorio / Banca: Paulo Tambasco de Oliveira / Resumo: Os objetivos deste estudo foram avaliar o efeito de biomateriais associados ao PRP na formação óssea em defeitos padronizados de rádio e avaliar o efeito de PRP+RTG+enxerto ósseo autógeno para tratamento de lesões de furca grau II em cães. Para tal, em um primeiro estudo, foram confeccionados 5 defeitos de 5mm em cada rádio (direito e esquerdo) em 05 cães, constituindo assim espaços para preenchimento com os enxertos ou substitutos ósseos avaliados, totalizando 50 cavidades. Os materiais testados foram DFDBA, vidro bioativo, osso autógeno e osso mineral bovino, associados ou não ao PRP. Estes grupos foram avaliados e comparados com os grupos representados por coágulo sangüíneo e PRP. Ao final de 60 dias, foi realizada biópsia e preparo laboratorial para avaliação histológica e histomorfométrica. Os grupos que apresentaram melhores resultados foram coágulo, PRP e osso autógeno associado ou não a PRP; e a utilização do PRP não promoveu maior formação óssea em relação aos demais grupos, com exceção do vidro bioativo+PRP que apresentou os melhores resultados. No segundo estudo, foram criados cirurgicamente defeitos periodontais de furca nos quartos pré-molares mandibulares, bilateralmente em 5 cães, cronificados por um período de três meses e tratados por PRP/RTG/enxerto ósseo autógeno (grupo experimental) ou RTG/enxerto ósseo autógeno (grupo controle). Quatro meses após o tratamento, os cães foram sacrificados. Na área de furca, houve maior preenchimento ósseo e extensão linear de novo cemento, nova adaptação conjuntiva e regeneração periodontal no grupo experimental (p<0.005) e maior extensão linear de epitélio no grupo controle (p<0.005). A associação do PRP a RTG e enxerto ósseo autógeno proporcionou maior regeneração dos tecidos periodontais. Portanto, o PRP promoveu melhores resultados na formação óssea somente... (Resumo completo, clicar acesso eletrônico abaixo). / Abstract: The aims of this study were to evaluate the effect of biomaterials in association to PRP on bone formation, in padronized defects of radius, and evaluate the effect of PRP/GTR/autogenous bone graft in the treatment of Class II furcation lesions in dogs. For that, in a first study, five defects of 5mm each were produced in each radius (left and right) in 5 dogs, so creating spaces to be filled with grafts or the bone substitutes under study, totalling 50 cavities. The biomaterials tested were DFDBA, bioglass, autogenous bone and bovine mineral bone grafts, associated, or not, with PRP. These biomaterials were compared with coagulum and PRP. At the end of 60 days biopsy was done and histological laminas were prepared. Under the experimental condictions, coagulum, PRP and autogenous bone associated or not to PRP presented the best results, with more new bone formation; and no difference was observed between the groups with biomaterials, associated or not with PRP, excepting bioactive glass/PRP which showded the best results. In the second study, periodontal furcation defects were surgically produced bilaterally in the fourth mandibular premolars in 5 dogs, cronified for 3 months and treated with PRP/GTR/autogenous bone graft (experimental group) or GTR/autogenous bone graft (control group). Four months after the treatment, the dogs were sacrified. In the furcation area, more bone filling and linear extension of new cement, new conjunctive adaptation and periodontal regeneration were observed to occur in the experimental group (p<0.005) and more linear extension of epitelium in the control group (p<0.005). The association PRP/GTR/autogenous bone graft was observed to produce more regeneration of periodontal tissues. Therefore, the PRP association showed the best results in bone formation only at bioactive glass group; and... (Complete abstract, click electronic address below). / Doutor

Membranas celulares (MCs; Cell Sheets), constituídas por células-tronco (CTs), são autodestacáveis da placa de cultivo, e sem subcultivos geram grande quantidade de células que podem ser transplantadas de maneira mais próxima da fisiologia celular, mantendo-se as ligações celulares e a matriz extracelular produzidas em cultura. O ácido ascórbico ou vitamina C (VC) tem efeito indutor da formação destas MCs, aumentando a longevidade e tempo de indiferenciação das CTs. A similaridade observada entre respostas biológicas da VC em MCs e aquelas da Laserfototerapia (LFT) sobre células e tecidos, nos levou à hipótese de que estas terapias poderiam se complementar melhorando o prognóstico de futura aplicação clínica dessas MCs em regenerações de tecidos de interesse odontológico. Para testar essa hipótese, LFT e VC foram aplicadas associadas ou não na indução de MCs de células-tronco da polpa dentária humana (hDPSCs). Para tanto, hDPSCs descongeladas, que expressaram níveis típicos de marcadores de superfície de células-tronco mesenquimais, foram plaqueadas em placas de 6 poços (5x104 células por poço). Vinte e quatro horas depois do plaqueamento as culturas foram submetidas aos tratamentos dos grupos experimentais: Controle: hDPSCs em P3 cultivadas com meio clonogênico; Senescente: hDPSCs em P27 cultivadas com meio clonogênico; VC: P3 cultivadas com meio clonogênico acrescido de VC (20 ?g/ml); Laser: P3 cultivadas com meio clonogênico e submetido à LFT (contato e pontual - 5 pontos / poço, 660 nm, 20 mW, 0,028 cm², 0,71 W/cm², 7 segundos, 5 J/cm², 0,14 J por ponto, 48 horas de intervalo) e Laser+VC: P3 cultivadas com meio clonogênico acrescido de VC e submetido à LFT. Em 24 horas, 7 e 13 dias as hDPSCs dos diferentes grupos experimentais foram observadas macro e microscopicamente, e atividade da enzima telomerase foi avaliada por PCR-TRAP, complementado por ELISA. Para a avaliação da expressão de genes relacionados à natureza e indiferenciação (Mitofilina e Oct 4) e à longevidade (fase catalítica da enzima telomerase - hTERT); bem como à senescência das células do grupo senescente (?-galactosidase), as hDPSCs de todos os grupos experimentais foram submetidas ao RT-qPCR As hDPSCs foram capazes de formar MCs somente nos grupos VC e Laser+VC (100%), entre 10 e 13 dias. As MCs do grupo Laser+VC apresentaram maior facilidade na manipulação. Atividade de Telomerase nas hDPSCs foi observada somente em 24 horas (Controle e LFT) e em 7 dias (VC e Laser+VC). Os marcadores de indiferenciação (Oct 4) e mesenquimal (mitofilina), bem como a hTERT foram expressos nas hDPSCs de todos os grupos experimentais. O Oct4 e o hTERT, em 7 dias, apresentaram expressões significativamente maiores nos grupos VC e Laser+VC em comparação com os demais (p < 0,0001, p = 0,0009, respectivamente). A expressão da mitofilina foi significativamente maior no grupo Laser+VC, em 7 dias (p =0,033). A técnica de obtenção de MCs de hDPSCs por essa metodologia foi considerada adequada para ser testada em procedimentos regenerativos. A LFT quando associada à VC não interferiu na formação das MCs, nem na manutenção da longevidade e indiferenciação das hDPSCs. Adicionalmente, a LFT melhorou a manipulação das MCs. Assim sendo, a associação de VC e LFT na indução de MCs parece promissora para futura utilização de MCs na odontologia regenerativa. / Cell Sheets, consisting of stem cells (SCs) are self detachable from the cultivation plate, and with no subcultivation can generate large amount of cells. The cell sheets can be transplanted closer to cell physiology environment by keeping the cell connections and the extracellular matrix produced in culture. Ascorbic acid or Vitamin C (VC) has inductive effect on cell sheet formation, increasing the longevity and the stemness of the cell for long period of time. The similarity between biological responses of VC in cell sheets and those of Laserphototherapy (LPT, Laser) on cells and tissues led us to hypothesize that these therapies could improve the prognosis of future clinical application of these cell sheets in regeneration of dental tissues. To test this hypothesis, LPT and VC were applied, associated or not, to induce human dental pulp stem cells (hDPSCs). Therefore, hDPSCs, which expressed typical levels of mesenchymal stem cell surface markers, were plated in 6-well plates (5x104 cells per well). Twenty-four hours later they were subjected to the treatment of experimental groups: Control: hDPSCs in P3 cultured with regular medium; Senescent: hDPSCs in P27 cultured with regular medium; VC: P3 cultured with regular medium supplemented with VC (20 ?g/ml); Laser: P3 cultures with regular medium and submitted to LPT (punctual and contact mode-5 points / well, 660 nm, 20 mW, 0.028 cm², 0.71 W/cm², 7 sec, 5 J/cm², 0.14 J per point, 48 hours-intervals) and Laser+VC: P3 cultured with regular medium supplemented with VC and submitted to LPT Within 24 hours, 7 and 13 days the hDPSCs of the different experimental groups were observed macroscopically and microscopically, and the telomerase enzyme activity was assessed by PCR-TRAP, complemented by ELISA. To evaluate the expression of genes related to the nature and differentiation (Mitofilina and Oct 4), longevity (catalytic phase of telomerase-hTERT enzyme), and the senescence of the senescent group cells (?-galactosidase), the hDPSCs of all experimental groups were subjected to RT-qPCR. The RT-qPCR data were compared by ANOVA complemented by the Tukey\'s test (p <= 0.05). The hDPSCs were able to form cell sheets only in the VC and Laser+VC groups (100%). Additionally, the cell sheets of the Laser+VC group presented easier handling. Telomerase activity in hDPSCs was observed only in 24 hours (Control and Laser) and seven days (VC and Laser + VC). The undifferentiating marker (Oct 4) and mesenchymal marker (mitofilin), as well as hTERT were expressed in hDPSCs of all experimental groups. Oct4 and hTERT presented expressions significantly higher at 7 days in VC and Laser+VC groups than in all other groups (p < 0.0001, p = 0.0009, respectively). The expression of mitofilin was significantly higher in the Laser+VC group, in 7 days (p = 0.0338). The technique of obtaining cell sheets of hDPSCs by the methodology here presented was considered appropriate to be further tested in regenerative procedures. The LPT when combined with VC did not interfere with the formation of the cell sheets, neither in the maintenance of longevity and undifferentiating status of hDPSCs. Moreover, LPT improved the handling of the cell sheets. Thus, the association of VC and LPT in the induction of cell sheets seems promising for future use in regenerative dentistry.

Sublinhagens de camundongos AIRmax e AIRmin homozigotas para os alelos R ou S do gene Slc11a1 apresentam distinta capacidade regenerativa à perfuração de suas orelhas. Animais AIRmaxSS exibiram regeneração tecidual precoce em comparação aos animais AIRmaxRR, sugerindo que o alelo S favorece a regeneração nestes animais. Camundongos das sublinhagens AIRmin não apresentaram regeneração após perfuração de suas orelhas. Em resposta ao estímulo, animais AIRmaxSS exibiram inflamação local mais intensa e tardia do que animais AIRmaxRR, demonstrando elevados níveis de MPO e edema, e influxo celular predominantemente de neutrófilos. Ensaios de expressão gênica global demonstraram genes diferencialmente expressos entre as sublinhagens, evidenciando genes sobre-representados no tema biológico proliferação celular em ambas sublinhagens, enquanto somente nos animais AIRmaxSS ocorreu sobre-representação para resposta inflamatória nos genes ativados e para contração muscular nos genes reprimidos. Os resultados de microarray foram validados por qPCR. / Homozygous AIRmax and AIRmin sublines for Slc11a1 R and S alleles present distinct regenerative capacity to the ear hole. AIRmaxSS mice exhibited early tissue regeneration compared to AIRmaxRR animals, suggesting that the Slc11a1 S allele promotes regeneration in these animals. AIRmin sublines didnt show regeneration after ear punch. In response to the stimulus, AIRmaxSS animals exhibited more intense and later local inflammation than AIRmaxRR animals, presenting elevated levels of MPO, edema and cellular influx predominantly of neutrophils. Global gene expression analysis showed differentially-expressed genes between the sublines, in which over-represented biological theme is cell proliferation in both sublines. AIRmaxSS animals displayed over-representation of inflammatory response in up-regulated genes and of muscle contraction in down-regulated genes. Microarray results were validated by using quantitative PCR.

The growing incidences of orthopedic problems globally have created a huge demand for strong bioactive materials for bone tissue engineering. Over the years, studies have shown chemical, physical, and mechanical properties of biomaterials influence the cellular interactions at the material-tissue interface, which subsequently controls biological response to materials. Strong biomaterials with surface properties that actively direct cellular response hold the key for engineering the next generation orthopedic implants. With its unique properties graphene can be used to reinforce poly (ε-caprolactone) (PCL) to prepare strong and bioactive polymer nanocomposites for bone tissue regeneration. The thesis entitled ―Engineering bioactive and multifunctional graphene polymer composites for bone tissue regeneration” systematically studies the effect of different chemically functionalized and metal-graphene hybrid nanoparticles in PCL composites for bone tissue engineering. The thesis comprises of seven chapters. Chapter 1 is an outline review on the impact of graphene and graphene derived particles to prepare supporting substrates for tissue regeneration and the associated cell response to multifunctional graphene substrate. This chapter discusses how cells interact with different graphene based particles and the interplay between cells performance and multifunctional properties of graphene based substrates. Chapter 2 describes the role, if any, of the functionalization of graphene on mechanical properties, stem cell response and bacterial biofilm formation. PCL composites of graphene oxide (GO), reduced GO (RGO) and amine-functionalized GO (AGO) were prepared at different filler contents (1%, 3% and 5%). Although the addition of the nanoparticles to PCL markedly increased the storage modulus, this increase was higher for GO and AGO than with RGO. In vitro cell studies revealed that the AGO and GO particles significantly increased human mesenchymal stem cell (hMSC) proliferation. AGO was most effective in augmenting stem cell osteogenesis leading to mineralization. Bacterial studies revealed that interaction with functionalized GO induced bacterial cell death due to membrane damage which was further accentuated by amine groups in AGO. The synergistic effect of oxygen containing functional groups and amine groups on AGO-reinforced composites renders the optimal combination of improved modulus, favorable stem cell response and biofilm inhibition desired for orthopaedic applications. In Chapter 3, toward preparing strong multi-biofunctional materials, poly(ethylenimine) (PEI) conjugated graphene oxide (GO_PEI) was synthesized using poly(acrylic acid) (PAA) as spacer and incorporated in PCL at different fractions. GO_PEI significantly promoted proliferation and formation of focal adhesions in hMSCs on PCL. GO_PEI was highly potent in inducing stem cell osteogenesis leading to 90% increase in alkaline phosphatase activity and mineralization over neat PCL with 5% filler content and was 50% better than GO. Remarkably, 5% GO_PEI was as potent as soluble osteo-inductive factors. Increased adsorption of osteogenic factors due to the amine and oxygen containing functional groups on GO_PEI augment stem cell differentiation. GO_PEI was also highly efficient in imparting bactericidal activity with 85% reduction in counts of E. coli colonies compared to neat PCL at 5% filler content and was more than twice as efficient as GO. This may be attributed to the synergistic effect of the sharp edges of the particles along with the presence of the different chemical moieties. Thus, in contrast to using labile biomolecules, GO_PEI based polymer composites can be utilized to prepare bioactive resorbable biomaterials for fabricating orthopedic devices for fracture fixation and tissue engineering. Chapter 4 describes the preparation of hybrid nanoparticles of graphene sheets decorated with strontium metallic nanoparticles and its advantages in bone tissue engineering. Strontium-decorated reduced graphene oxide (RGO_Sr) nanoparticles were synthesized by facile reduction of graphene oxide and strontium nitrate. X-ray diffraction, transmission electron microscopy, and atomic force microscopy revealed that the hybrid particles were composed of RGO sheets decorated with 200 – 300 nm metallic strontium particles. Thermal gravimetric analysis further confirmed the composition of the hybrid particles as 22 wt% of strontium. Macroporous tissue scaffolds were prepared incorporating RGO_Sr particles in PCL. The PCL/RGO_Sr scaffolds were found to elute strontium ions in aqueous medium. Osteoblast proliferation and differentiation was significantly higher in the PCL scaffolds containing the RGO_Sr particles in contrast to neat PCL and PCL/RGO scaffolds. The increased biological activity can be attributed to the release of strontium ions from the hybrid nanoparticles. This study demonstrates that composites prepared using hybrid nanoparticles that elute strontium ions can be used to prepare scaffolds with osteoinductive property. These findings have important implications for designing the next generation of biomaterials for use in tissue regeneration. Chapter 5 discusses the use of hybrid graphene-silver particles (RGO_Ag) to reinforce PCL and compared with PCL/RGO and PCL/Ag composites containing RGO and silver nanoparticles (AgNPs), respectively. RGO_Ag hybrid particles were well dispersed in the PCL matrix unlike the RGO and AgNPs due to enhanced exfoliation. RGO_Ag led to 77 % increase in the modulus of PCL and provided a conductive network for electron transfer. Electrical conductivity increased four orders of magnitude from 10-11 S/cm to 10-7 S/cm at 5 wt % filler that greatly exceeded the improvements with the use of RGO and AgNP in PCL. RGO_Ag particles reinforced in PCL showed sustained release of silver ions from the PCL matrix unlike the burst release from PCL/Ag. PCL/RGO_Ag and PCL/RGO composites were non-toxic to hMSCs and supported osteogenic differentiation unlike the PCL/Ag composites which were highly toxic at ≥3% filler content. The PCL/RGO_Ag composites exhibited good antibacterial effect due to a combination of silver ion release from the AgNPs and the mechanical rupture induced by the RGO in the hybrid nanoparticles. Thus, the synergistic effect of Ag and RGO in the PCL matrix uniquely yielded a multifunctional material for use in implantable biomedical devices and tissue engineering. Chapter 6 presents investigation of potential differences in the biological response to graphene in polymer composites in the form of 2D substrates and 3D scaffolds. Results showed that osteoblast response to graphene in polymer nanocomposites is markedly altered between 2D substrates and 3D scaffold due to the roughness induced by the sharp edges of graphene at the surface in 3D but not in 2D. Osteoblast organized into aggregates in 3D scaffolds in contrast to more well spread and randomly distributed cells on 2D discs due to the macro-porous architecture of the scaffolds. Increased cell-cell contact and altered cellular morphology led to significantly higher mineralization in 3D scaffolds compared to 2D. This study demonstrates that the cellular response to nanoparticles in composites can change markedly by varying the processing route. Chapter 7 summarizes the important results and future directions of the work. This chapter provides general conclusions arising from this study, and makes suggestions for future work designed to provide a greater understanding of the in vivo response in terms of bio-distribution of the released functionalized graphene from the scaffold or substrate must be assessed with special attention on their accumulation or excretion.

Nous avons déterminé la capacité de régénération du tissu vasculaire in vivo des CSM traitées avec BMP2 à la dose de [100 ng.mL-1] dans un modèle rat. Nous avons ainsi rapporté qu’une prothèse revêtue de CSM traitée par BMP2 pendant 1 semaine et implantée 14 jours chez le rat permettait la reconstitution des trois tuniques de la paroi mimant la structure de l’aorte. La capacité proangiogénique des CSM était augmentée par BMP2 grâce à la mise en jeu de voies intracellulaires impliquant le facteur induit par l’hypoxie (HIF-1α) via JAK/STATs. Nous avons montré que les CSM migraient sous l’influence de BMP2 par stimulation de l’activité du complexe enzymatique NADPH oxydase via l’augmentation de l’expression des protéines PAK1, Vav2 et RAC1 GTPase/PI3K. Ce travail a confirmé l’intérêt de l’utilisation de CSM conjointement à rh-BMP2, une protéine impliquée dans l’embryogénèse vasculaire, pour la bioingénierie de la régénération vasculaire. / We determined the capacity to regenerate vascular tissue in vivo, of MSC treated with BMP2 at a dose of [100 ng.mL-1] in a rat model. We have reported that a prosthesis coated with CSM treated 1 week with BMP2 and implanted in rats 14 days allowed the reconstruction of the three tunics of the wall that mimic the structure of the aorta. The proangiogenic capacity of MSCs was increased by BMP2 through the intracellular pathways involving hypoxia inducible factor (HIF-1α) via JAK / STAT. We have shown that MSCs migrated under the influence of BMP2 by stimulating the activity of the enzyme complex NADPH oxidase via the increased expression of PAK1 protein, Vav2 and RAC1 GTPase/PI3K. This work confirmed the interest of the use of MSC in conjunction with rh-BMP2, a protein involved in vascular embryogenesis for bioengineering for vascular regeneration.

A odontologia, atualmente, conta com uma nova abordagem terapêutica no campo da regeneração tecidual. Essa abordagem baseia-se no uso de moléculas bioativas, mais especificamente as BMPs (Bone Morphogenetic Proteins). A presente revisão propõe-se a apresentar alguns relatos, existentes na literatura, do uso das BMPs como medicamento, dando embasamento para realização de novos experimentos que possam sugerir abordagens terapêuticas inovadoras na área da regeneração tecidual. As BMPs são proteínas pleiotrópicas, que estão envolvidas no desenvolvimento de vários órgãos do corpo humano, e, também, estão presentes nas várias fases da morfogênese dentária, controlando e modulando as atividades celulares. As BMPs têm o potencial de serem usadas, tanto para a regeneração do complexo dentina-polpa quanto para a regeneração do periodonto (osso, cemento, ligamento, gengiva), podem ser empregadas em cirurgias craniofacial para correção de anomalias adquiridas ou herdadas, correção de seqüelas de trauma craniano, seqüelas de câncer, defeitos ósseos e reparo da cartilagem têmporomandibular. Deste trabalho pode-se concluir que a BMP: (1) tem importância na regeneração tecidual como elemento chave na engenharia de tecido; (2) oferece a vantagem de ser uma abordagem mais biológica, gerando um tecido idêntico ao perdido; (3) tem sido bem estudada em vários experimentos clínicos, com muito sucesso, inclusive em humanos; e (4) poderá estar disponível como uma alternativa de terapia a ser empregada no consultório odontológico. / Nowadays, odontology counts on a new therapeutic approach in the field of tissue regeneration. This approach is based in the use of bioactive molecules, specifically the BMPs (Bone Morphogenetic Proteins). The present revision has in view to know the BMPs and its applications as medicines, offering support to the accomplishment of experiments that could suggest new proposes of treatment in the field of tissue regeneration. The BMPs are pleiotropic proteins that are involved in the development of many organs of the human body and they are also present in the several phases of dental morphogenesis, controlling and modulating the cellular activities. The BMPs have the potential to be used to the regeneration of the dentin-pulp complex as much as to the regeneration of the periodontium (bone, cementum, ligament and gingiva), and can be used in facial and cranial surgeries to the correction of acquired or inherited anomalies, correction of cranial trauma consequences, bone defects and repair of the temporal- mandible cartilage. From this review, we can conclude some topics about the BMP: (1) it has importance in the tissue regeneration as a key element in tissue engineering; (2) the BMP offers the advantage of being a more biologic approach, generating a new tissue that is identic to the lost one; (3) it has been studied in several clinic experiments, with great success, even including humans; (4) it probably will be available as an alternative of therapy, that may be used in odontologic rooms in the future.

Despite tremendous progress in medicine, injuries of the adult central neural system remain without satisfactory solution. Regenerative medicine employs tissue engineering, cellular therapies, medical devices, gene therapy, or growth factors with the aim to bridge the lesion, re-establish lost connections and enhance endogenous repair in order to restore neural function. The aim of my thesis was to evaluate therapeutic potential of two approaches, transplantation of human mesenchymal stromal cells (hMSCs) and biological scaffolds derived from extracellular matrix (ECM) for neural regeneration, particularly in models of spinal cord injury (SCI). First, hMSCs from various sources - bone marrow (BM), adipose tissue (AT) and Wharton's jelly (WJ) - were isolated and characterized in vitro. All cell types met the minimal criteria for MSC phenotype and displayed similar properties in terms of their surface marker expression, differentiation potential, migratory capacity, and secretion of cytokines and growth factors. On the other hand, the cell yield from WJ and AT was significantly higher, and MSCs isolated from these tissues proliferated better than from BM. Therapeutic effect of intrathecal application of hWJ-MSCs was then evaluated in SCI compression model in rats. The effect of low (0.5 million) and...

[ES] Las células mesenquimales estromales (MSC) poseen una serie de cualidades inmunológicas, pro-angiogénicas y regenerativas que las convierten en un excelente candidato para el tratamiento de diversas patologías. A pesar de las pruebas contundentes obtenidas en modelos preclínicos que demuestran la actividad terapéutica de las MSC, los ensayos clínicos no han podido mostrar hasta ahora un beneficio consistente, probablemente debido a deficiencias metodológicas y a la falta de estandarización, así como a la variabilidad genética intrínseca a los estudios en humanos. Debido a ello, ha sido necesario profundizar en los mecanismos responsables del beneficio terapéutico y rediseñar las estrategias clínicas. En los últimos años, se ha observado que la reparación tisular mediada por las MSC se produce de forma paracrina, y se ha constatado que las vesículas extracelulares (EVs) secretadas por las MSC (EVMSC) son capaces de recapitular las propiedades inmunosupresoras de las células parentales. Además, las estrategias terapéuticas basadas en vesículas tienen grandes ventajas en términos de bioseguridad y producción en condiciones de grado clínico, reduciendo significativamente el coste de dichas terapias. Sin embargo, la dosis efectiva en grandes mamíferos, incluidos los humanos, es bastante elevada y la producción industrial de EVs se ve dificultada en parte, por la senescencia proliferativa que afecta a las MSC durante la expansión celular masiva. En este trabajo hemos intentado solventar los principales escollos de la terapia con EVs incrementando su potencial inmunosupresor y reduciendo por tanto la dosis efectiva. Este incremento se ha conseguido gracias a la sobreexpresión del factor inducible por hipoxia 1-alpha y al desarrollo de un medio de acondicionamiento en cultivo basado en citoquinas. Además, la inmortalización de las células secretoras mediante la transducción del gen de la telomerasa humana ha permitido tanto la estandarización del producto como su producción a gran escala. La eficacia de estas EVs ha sido testada en diferentes poblaciones celulares in vitro: linfocitos T, monocitos, células Natural Killer, macrófagos, células endoteliales y fibroblastos; y en dos modelos de ratón: hipersensibilidad retardada y colitis aguda inducida por TNBS. En conclusión, hemos desarrollado una fuente de EVs de larga duración que secreta grandes cantidades de vesículas con mayor capacidad inmunosupresora y antiinflamatoria, facilitando un producto terapéutico más estándar y fácil de producir para el tratamiento de enfermedades inflamatorias inmunomediadas. / [CA] Les cèl·lules mesenquimals estromals (MSC) posseeixen una sèrie de qualitats immunològiques, pro-angiogèniques i regeneratives que les converteixen en un excel·lent candidat per al tractament de diverses patologies. Tot i les proves contundents obtingudes en models preclínics que demostren l'activitat terapèutica de les MSC, els assaigs clínics no han pogut mostrar fins ara un benefici consistent, probablement degut a deficiències metodològiques i a la manca d'estandardització, així com a la variabilitat genètica intrínseca als estudis en humans. A causa d'això, ha calgut aprofundir en els mecanismes responsables del benefici terapèutic i redissenyar les estratègies clíniques. En els últims anys, s'ha observat que la reparació tissular intervinguda per les MSC es produeix de forma paracrina, i s'ha constatat que les vesícules extracel·lulars (EVs) secretades per les MSC (EVMSC) són capaços de recapitular les propietats immunosupressores de les cèl·lules parentals. A més, les estratègies terapèutiques basades en vesícules tenen grans avantatges en termes de bioseguretat i producció en condicions de grau clínic, reduint significativament el cost d'aquestes teràpies. No obstant això, la dosi efectiva en grans mamífers, inclosos els humans, és bastant elevada i la producció industrial de les EVs es veu dificultada en part, per la senescència proliferativa que afecta les MSC durant l'expansió cel·lular massiva. En aquest treball hem intentat solucionar els principals esculls de la teràpia amb EVs incrementant el seu potencial immunosupressor i reduint per tant la dosi efectiva. Aquest increment s'ha aconseguit gràcies a la sobreexpressió del factor induïble per hipòxia 1-alpha i a el desenvolupament d'un mitjà de condicionament en cultiu basat en citoquines. A més, la immortalització de les cèl·lules secretores mitjançant la transducció del gen de la telomerasa humana ha permès tant l'estandardització del producte com la seva producció a gran escala. L'eficàcia d'aquestes EVs ha estat testada en diferents poblacions cel·lulars in vitro: limfòcits T, monòcits, cèl·lules Natural Killer, macròfags, cèl·lules endotelials i fibroblasts; i en dos models de ratolí: hipersensibilitat retardada i colitis aguda induïda per TNBS. En conclusió, hem desenvolupat una font de EVs de llarga durada que secreta grans quantitats de vesícules amb major capacitat immunosupressora i antiinflamatòria, facilitant un producte terapèutic més estàndard i fàcil de produir per al tractament de malalties inflamatòries inmunomediades. / [EN] Mesenchymal stromal cells (MSC) possess several immunological, pro-angiogenic and regenerative qualities that make them an excellent candidate for the treatment of various pathologies. Despite compelling evidence from preclinical models demonstrating the therapeutic activity of MSCs, clinical trials have so far failed to show consistent benefit, probably due to methodological shortcomings and lack of standardisation, as well as the genetic variability intrinsic to human studies. As a result, it has been necessary to further investigate the mechanisms responsible for therapeutic benefit and to redesign clinical strategies. In recent years, it has been observed that MSC-mediated tissue repair occurs in a paracrine pathway, and it has been confirmed that extracellular vesicles (EVs) secreted by MSC (EVMSC) are able to recapitulate the immunosuppressive properties of the parental cells. Moreover, vesicle-based therapeutic strategies have great advantages in terms of biosafety and production under clinical-grade conditions, significantly reducing the cost of such therapies. However, the effective dose in large mammals, including humans, is quite high and the industrial production of EVs is hampered in part by the proliferative senescence that affects MSC during massive cell expansion. In this work, we have attempted to overcome the main challenges of EVs therapy by increasing their immunosuppressive potential and thus reducing the effective dose. This increase has been achieved by overexpression of hypoxia-inducible factor 1-alpha and the development of a cytokine-based culture conditioning medium. In addition, immortalization of secretory cells by transduction with the human telomerase gene has allowed both product standardisation and large-scale production. The efficacy of these EVs has been tested in different cell populations in vitro: T lymphocytes, monocytes, Natural Killer cells, macrophages, endothelial cells and fibroblasts; and in two mouse models: delayed-type hypersensitivity and TNBS-induced acute colitis. In conclusion, we have developed a long-lasting source of EVs that secretes large amounts of vesicles with enhanced immunosuppressive and anti-inflammatory capacity, providing a more standard and easier-to-produce therapeutic product for the treatment of immune-mediated inflammatory diseases. / Gómez Ferrer, M. (2022). Terapias innovadoras basadas en vesículas extracelulares derivadas de células madre mesenquimales modificadas genéticamente [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/182560 / TESIS

No / Infection is the major reason of GTR/GBR membrane failure in clinical application. In this work, we developed GTR/GBR nanofiber membranes with localized drug delivery function to prevent infection. Metronidazole (MNA), an antibiotic, was successfully incorporated into electrospun polycaprolactone (PCL) nanofibers at different concentrations (0, 1, 5, 10, 20, 30, and 40 wt% polymer). To obtain the optimum anti-infection membrane, we systematically investigated the physical-chemical and mechanical properties of the nanofiber membranes with different drug contents. The interaction between PCL and MNA was identified by molecular dynamics simulation. MNA released in a controlled, sustained manner over 2 weeks and the antibacterial activity of the released MNA remained. The incorporation of MNA improved the hydrophilicity and in vitro biodegradation rate of PCL nanofibers. The nanofiber membranes allowed cells to adhere to and proliferate on them and showed excellent barrier function. The membrane loaded with 30% MNA had the best comprehensive properties. Analysis of subcutaneous implants demonstrated that MNA-loaded nanofibers evoked a less severe inflammatory response than pure PCL nanofibers. These results demonstrate the potential of MNA-loaded nanofiber membranes as GTR/GBR membrane with antibacterial and anti-inflammatory function for extensive biomedical applications.